FdaApplication
ANDA 213342
Identifiers
- fda_app_no: ANDA213342
Properties
| Property | Value |
|---|---|
| applicant_name | ACCORD HEALTHCARE INC |
| application_type | ANDA |
| approval_date | 2020-04-07 |
Products (4)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| HYDROXYCHLOROQUINE SULFATE | HYDROXYCHLOROQUINE SULFATE | 100MG | TABLET;ORAL |
| HYDROXYCHLOROQUINE SULFATE | HYDROXYCHLOROQUINE SULFATE | 300MG | TABLET;ORAL |
| HYDROXYCHLOROQUINE SULFATE | HYDROXYCHLOROQUINE SULFATE | 200MG | TABLET;ORAL |
| HYDROXYCHLOROQUINE SULFATE | HYDROXYCHLOROQUINE SULFATE | 400MG | TABLET;ORAL |
4 products